De Yong Wen
Amministratore Delegato presso SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Patrimonio netto: 611 566 $ in data 30/04/2024
Profilo
De Yong Wen is currently the Co-Chief Executive Officer & Executive Director at Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
He is also the Chairman-Supervisory Board at China National Accord Medicines Corp.
Ltd., a Non-Executive Director at Sinopharm Group Co., Ltd., a Director at China National Medicines Co., Ltd., a Director at Sinopharm Industrial Investment Co., Ltd., and a Non-Executive Director at Shanghai Henlius Biotech, Inc. Previously, Mr. Wen held positions as Vice Chairman at Chongqing Yao Pharmaceutical Co., Ltd.
and Director at C.Q.
Pharmaceutical Holding Co., Ltd.
Mr. Wen obtained an MBA from Donghua University in 2007 and an undergraduate degree from West China University of Medical Sciences in 1995.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 13/12/2022 | 187 100 ( 9.50% ) | 611 566 $ | 30/04/2024 |
Posizioni attive di De Yong Wen
| Società | Posizione | Inizio |
|---|---|---|
| SINOPHARM GROUP CO. LTD. | Direttore/Membro del Consiglio | 01/09/2017 |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Direttore/Membro del Consiglio | 09/05/2019 |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Amministratore Delegato | 01/06/2022 |
| SHANGHAI HENLIUS BIOTECH, INC. | Direttore/Membro del Consiglio | 28/07/2022 |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Presidente | 10/07/2019 |
Sinopharm Industrial Investment Co., Ltd.
 Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Direttore/Membro del Consiglio | 20/01/2020 |
Precedenti posizioni note di De Yong Wen
| Società | Posizione | Fine |
|---|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
 Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Direttore/Membro del Consiglio | - |
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Direttore/Membro del Consiglio | - |
Formazione di De Yong Wen
| West China University of Medical Sciences | Undergraduate Degree |
| Donghua University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Health Technology |
| SINOPHARM GROUP CO. LTD. | Health Technology |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Health Technology |
Sinopharm Industrial Investment Co., Ltd.
Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Finance |
- Borsa valori
- Insiders
- De Yong Wen